GlassScriptPhysician profile
Laila F Chagani
NPI 1225026586
$1,750.37
in general payments reported to CMS, 2019-2025
15 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $37.18 · 2021: $29.97 · 2022: $178 · 2023: $141 · 2024: $26.49 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $1,159.49 | 2019 | |
| Viiv Healthcare Company | $139.20 | 2022-2025 | Apretude |
| Vanda Pharmaceuticals INC. | $84.09 | 2022 | |
| Philips North America LLC | $67.54 | 2025 | Vest Therapy Und |
| Gilead Sciences, INC. | $65.54 | 2023-2025 | Biktarvy |
| Cranial Technologies, INC | $44.16 | 2020-2022 | |
| Averitas Pharma INC. | $26.49 | 2024 | Qutenza |
| Alnylam Pharmaceuticals INC. | $25.53 | 2023 | Givlaari |
| Ethicon US, LLC | $24.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.42 | 2020 | |
| Exact Sciences Corporation | $21.17 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $20.00 | 2023 | Thinprep 2000 Processor, Aptima |
| Novo Nordisk INC | $18.76 | 2025 | |
| Phadia US INC. | $16.92 | 2021 | |
| Glaxosmithkline, LLC. | $14.32 | 2025 | Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laila Chagani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.